bpc-157 fda approved status This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the will make bpc 157 fda classification Survey:

| Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice, attracting growing interest in regenerative medicine for tendon and ligament repair

Some peptide therapies discussed on this page may be prepared by licensed compounding pharmacies when prescribed by a qualified healthcare provider

The single human dataset for musculoskeletal use is a retrospective chart review of sixteen knee-pain patients who paid for intra-articular injections, with subjective improvement reported in fourteen and no control, no blinded assessment, and no objective imaging endpoint

Early data and anecdotal reports indicate the half-life of BPC-157 might range anywhere from a few hours up to 24 hours, though precise data is limited